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ABSTRACT. Amyloid aggregation of human islet amyloid polypeptide (IAPP) is a hallmark of 
type 2 diabetes (T2D), a metabolic disease and a global epidemic. Although IAPP is synthesized 
in pancreatic β-cells, its fibrils and plaques are found in the extracellular space indicating a 
causative transmembrane process. Numerous biophysical studies have revealed that cell 
membranes as well as model lipid vesicles promote the aggregation of amyloid-β (associated with 
Alzheimer’s), α-synuclein (associated with Parkinson’s) and IAPP, through electrostatic and 
hydrophobic interactions between the proteins/peptides and lipid membranes. Using a thioflavin 
T kinetic assay, transmission electron microscopy, circular dichroism spectroscopy, discrete 
molecular dynamics simulations as well as free energy calculations here we show that micellar 
lysophosphatidylcholine (LPC), the most abundant lysophospholipid in the blood, inhibited the 
amyloid aggregation of IAPP through nonspecific interactions while elevating the α-helical 
peptide secondary structure. This surprising finding suggests a native protective mechanism 
against IAPP aggregation in vivo. 
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Introduction  
Human islet amyloid polypeptide (IAPP) is an endocrine hormone that, in its monomeric form, 
regulates glucose metabolism in cooperation with insulin. However, IAPP is aggregation prone 
sans the stabilisation of insulin, physiological metal ions, low pH,1-6 or their complexation with 
zinc and C-peptide,7 and accumulating evidence has implicated IAPP amyloid aggregation as a 
hallmark of pancreatic β-cell death and type-2 diabetes (T2D), a disease impairing millions of 
people worldwide with profound social and economic implications.  
IAPP is synthesised in pancreatic β-cells and co-released with insulin to blood circulation for 
glycemic control.1 IAPP fibrils and plaques, however, appear in the extracellular space of the 
Langerhans suggesting a role of cell membranes in inducing aberrant IAPP aggregation. Indeed it 
has been shown in the literature that cell membranes as well as lipid vesicles generally promote 
IAPP aggregation,8-19 as also observed for amyloid-β and α-synuclein in neurodegenerative 
disorders.20,21 Conversely, IAPP disrupts membrane integrity through lipid extraction or pore 
formation.13,15,19,20 On the molecular level, the binding between IAPP and a lipid interface is 
initiated by the N-terminus of the peptide, through electrostatic interaction with the anionic lipids 
and facilitated by hydrophobic interaction engaging the lipid bilayer and the amphiphilic peptide 
oligomers, protofibrils and fibrils.8-12,14 Among these, oligomeric IAPP has been widely 
acknowledged as the toxic species based on in vitro and animal studies.1,8  
Upon release into the bloodstream IAPP is exposed to a myriad of plasma proteins and lipids, yet 
the impact of such exposure on IAPP conformation and toxicity has rarely been studied. Recently 
we have proposed the concept of protein corona for elucidating the physicochemical and structural 
transformations of IAPP in circulation.22 In this study we examined the effects of zwitterionic 
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lysophosphatidylcholine (LPC) at both below and above its critical micelle concentration (CMC, 
40-50 μM)23 on IAPP aggregation. LPC is the most abundant single-tailed phospholipid in the 
blood (234 μM)24 as well as a signaling molecule in the cell membrane. At concentrations above 
the CMC, such as in the blood, LPC molecules render ultra-small micelles (~4 nm in diameter)25,26 
in size similar to that of sodium dodecyl sulfate (SDS). From the perspective of a model membrane 
the zwitterionic LPC micelles mimic the largely neutral pancreatic β-cell membranes (97.5% 
neutral, plus 2.5% anionic lipids)27 more closely than the anionic SDS that has been used as a 
model system for examining protein-membrane interactions.  
The fibrillisation of IAPP in the presence of linear and micellar LPC was quantified by a thioflavin 
T (ThT) kinetic assay and high-resolution transmission electron microscopy (TEM). The changing 
secondary structure of IAPP in the presence of linear and micellar forms of the lipid was probed 
with circular dichroism (CD) spectroscopy. A surprising inhibition effect of LPC micelles on IAPP 
amyloid aggregation was revealed, characterized by a prolonged lag time, a reduction in the β-
sheet content at saturation, and sparse formation of soft, braided IAPP fibrils. Atomistic discrete 
molecular dynamic (DMD) simulations28 were performed to provide molecular details of IAPP-
LPC interaction. Upon binding the micelles, the C-terminal region of IAPP that is unstructured in 
solution29 started to adopt an α-helical conformation. The hydrophobic interfaces of the 
amphiphilic N- and C-terminal helixes were buried at the lipid head-tail interface, forming a well-
defined IAPP-micelle complex to inhibit the self-association and aggregation of IAPP. 
Results and discussion 
Effects of LPC binding on IAPP fibrillisation and remodelling - experiments   
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Biophysical characterisations revealed the differential effects of micellar and non-micellar LPC 
on IAPP fibrillisation, and additionally, their capacities in remodelling of mature IAPP amyloids 
(Fig. 1). Native fibrillisation of IAPP, which forms long, semi-flexible amyloid fibrils in aqueous 
solution over 24 h, was notably inhibited by micellar LPC (Fig. 1B). ThT fluorescence indicated 
a reduction in the β-sheet content formed by IAPP in the presence of micellar LPC by 24 h, 
compared to the IAPP control (Fig. 1A). Non-micellar LPC induced a lag time of only ~10 min 
and the saturation point was reached ~2 h before the IAPP control. This effect has also been 
observed with the Alzheimer's-related amyloid-β, where LPC below the CMC was capable of 
reducing the fibril lag and elongation times of amyloid-β1-42, yet showed no notable increase in 
fibrillisation after saturation was reached in each case.30 Anionic non-micellar lipids, including 
SDS31 and lysophosphatidic acid (LPA)32, have demonstrated the capacity to promote fibrillisation 
and fibril elongation of β2-microglobulin (β2M) at a neutral pH, though zwitterionic LPC did not 
mediate any significant effect.  
The interaction of micellar LPC with IAPP, in contrast, greatly reduced IAPP fibrillisation, both 
in terms of fibrillisation kinetics and overall amyloid formation by 24 h. CD spectroscopy revealed 
the transition of peptide secondary structure from random coils to β sheets over 24 h (Fig. 1C). In 
the presence of non-micellar LPC, an increase in β-sheet content of ~15% was observed for IAPP 
by 24 h, while the α-helical content (< 10%) showed negligible variations over the experimental 
period. In contrast, interactions of IAPP with LPC micelles induced an immediate transition from 
β sheets to α helices (39.2%). Within the IAPP-LPC micelle complex, IAPP random coils remained 
stable over 24 h (~33%). In contrast, Patil et al. observed that upon complexation with SDS 
micelles, IAPP residues 5-28 were present in the α-helical conformation, with residues 5-19 
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embedded in the hydrophobic core, and the known amyloidogenic region (residues 20-29) 
positioned on the surface of the micelle at the lipid-solvent interface.14  
Given the limited capacity for inter-peptide interactions between micelle-bound IAPP, disruption 
of IAPP fibrillisation is expected. Indeed, visualisation of IAPP amyloid fibrils after 24 h in 
aqueous solution demonstrated significant structural polymorphism of IAPP fibrils in the presence 
of micellar LPC by TEM imaging (Fig. 1B) and subsequent analysis of fibril diameter (Fig. 1D). 
Large, braided amyloid fibrils larger than 30 nm in diameter were observed (Fig. 1B), displaying 
a significantly broadened distribution compared with the IAPP control or IAPP treated with non-
micellar LPC (Fig. 1D), though fewer fibrils were seen. The fibrils appeared softer, with a 
persistence length of 458 ± 13 nm based on FiberApp statistical analysis,33 compared with that of 
2,885 ± 60 nm for the IAPP control.34 Below the CMC, LPC remodelled amyloid fibrils into 
filaments of thinner width (Fig. 1D). Micellar LPC (Fig. S1, 4-5 nm in size) did not remodel pre-
formed fibrils, but similarly to their effect on fibrillating IAPP, individual fibrils were observed to 
closely associate, belying the 'glue-like' effect of LPC micelles on mature amyloids.  
Effects of LPC binding on IAPP structure by discrete molecular dynamics simulations   
Micellar LPC inhibits IAPP aggregation. Each LPC micelle comprised of 50 LPC lipid 
monomers was pre-assembled and equilibrated by DMD simulations, rendering a micellar 
diameter of ~4 nm (Methods). Simulations of IAPP peptides and LPC micelles were performed at 
a 2:2 ratio to investigate the effect of LPC micelles on IAPP self-association. The control 
simulations of two IAPPs alone were carried out at the same concentration. Averaging over 20 
independent simulations, the self-association of IAPP was monitored by computing the average 
number of atomic contacts between the two IAPPs as well as the binding between the IAPP and 
the micelle as a function of time (Fig. 2A). Indeed, the self-association of IAPPs was significantly 
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reduced (Fig. 2A, upper panel) due to their higher tendency to bind micelles (Fig. 2A, lower panel). 
To characterise the interactions of LPC micelles with IAPP, the binding frequency of each IAPP 
residue with either the hydrophobic tails or hydrophilic heads of LPCs was calculated (Fig. 2B). 
The hydrophobic tails of LPCs in the micelle core preferentially bound to the hydrophobic residues 
of IAPP, i.e., L12, F15, L16, F23, I26, L27 and Y37 (Fig. 2B inset). The hydrophilic residues of 
IAPP had higher binding frequencies with the phosphorylcholine heads of LPCs than their 
hydrophobic tails, indicating a stable IAPP-micelle complex formation by burying the 
hydrophobic IAPP residues into the hydrophobic core of the LPC micelle and exposing the 
hydrophilic IAPP residues on the surface. In the presence of LPC micelles, the overall helical 
content of IAPP increased while the β-strand and turn contents decreased compared to IAPPs alone 
(Fig. 2C), which is consistent with the CD experiment (Fig. 1C). In particular, the increased α-
helix propensities were mainly in residues 18-29, approximately corresponding to the IAPP 
amyloidogenic region (Fig. 2D).35 To better characterise the structural properties of IAPPs in the 
presence and absence of LPC micelles, a two-dimensional potential of mean force (2D-PMF, or 
effective free energy) was computed with respect to the radius of gyration (Rg) and the number of 
residues in helix conformations (Nhelix) (Fig. 2E, 2F), 𝑃𝑀𝐹 =  −𝐾𝐵𝑇𝑙𝑛𝑃(𝑅𝑔, 𝑁ℎ𝑒𝑙𝑖𝑥) + C, where 
KB is the Boltzmann constant, T the simulation temperature at 300 K, and C a constant set to render 
the lowest PMF value at zero. Compared to the control simulations of an IAPP dimer, the energy 
basins of IAPPs in the presence of LPC micelles shifted toward larger Nhelix values with a new 
basin emerging at Nhelix ~12 and larger Rg values. By burying the hydrophobic residues of the 
amphiphilic helices at the N- and C-termini in the micelle, IAPPs became extended on the micelle 
surface, while IAPPs alone formed a more compact dimer structure stabilised by inter-chain 
hydrogen bonds and hydrophobic interactions (snapshots in the inset of Fig. 2E, 2F corresponding 
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to the indicated PMF basins). The simulations suggest that LPC micelles prevented IAPP self-
association and aggregation by stabilising IAPP monomers in the IAPP-micelle complexes. In 
addition, the small size of LPC micelles and their correspondingly large curvature also stabilised 
the surface-bound IAPPs in the monomeric form, hence preventing formation of -sheet rich 
amyloid fibrils due to the geometric impartibility between a flat -sheet and the highly curved 
binding surface. 
Soluble LPCs promote IAPP self-association. The effect of LPC monomers on IAPP self-
association was examined by simulating the self-assembly of six IAPP peptides in the presence 
and absence of 24 initially isolated LPC molecules (Methods). To quantify the self-association of 
IAPPs, a single-linkage clustering analysis of snapshot structures along the simulation trajectories 
was performed: two molecules formed a cluster if they were in contact (i.e., making at least one 
intermolecular contact) and a molecule belonged to a cluster if it was in contact with any of the 
member molecules. In the presence of LPCs, the average number of IAPP-containing clusters 
rapidly dropped from 6 to 2 while the control simulations still had ~4 clusters after 200 ns (Fig. 
3A). Using the last 25 ns of all simulations, we compared the distribution of mass-weighted IAPP 
cluster sizes in the presence and absence of initially isolated LPC monomers, where the presence 
of LPC monomers enhanced the self-association of IAPPs for larger oligomers (Fig. 3B). 
Compared to LPC micelles, these initially isolated LPCs had similar binding profiles to IAPP 
residues, but with overall stronger hydrophobic interactions (Fig. 3C) due to a higher accessible 
hydrophobic surface per lipid. The snapshots from 6 IAPPs with initially isolated LPCs illustrated 
the process of co-aggregation of IAPPs with LPCs (Fig. 3D). IAPP initially bound to one or several 
LPCs due to strong hydrophobic interaction and formed small and then large IAPP-LPC complexes 
with increased hydrophobic surfaces (150 & 200 ns; Fig. 3D). Therefore, these results suggest that 
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the presence of LPC monomers accelerated the self-association of IAPPs. Since the timescales 
accessible to atomistic DMD simulations were much shorter than the aggregation kinetics in 
experiments, no significant changes in IAPP secondary structure were observable with and without 
LPCs (data not shown).  
Binding of LPC with IAPP amyloid fibril. The binding of LPC lipids with a two-layered IAPP 
amyloid fibril was examined. The fibril model consisted of 40 peptides (Fig. S3), reconstructed 
based on solid-state NMR constraints (Methods).36 30 independent simulations of 160 LPC 
monomers with randomly assigned initial positions and orientations around the fibril were 
performed, where the model fibril was fixed and LPCs were allowed to move freely. The 
distributions of LPC clusters in solution and bound to the fibril were calculated (Fig. 4A). In 
solution, the lipids self-assembled into various clusters or micelles with still isolated monomers. 
LPC could also bind the fibril and form larger clusters on the fibril surface (e.g., the large cluster 
of ~100 LPCs in the inset of Fig. 4A). The binding profile of LPCs with different IAPP residues 
in the fibril (Fig. 4B) was highly selective compared to free IAPPs (Figs. 2D & 3C). Interestingly, 
residues with high binding frequencies to LPCs formed four consecutive surface patches on the 
fibril surface or two LPC binding sites due to the two-fold symmetry of the fibril along the axis. 
One of the binding sites was around hydrophobic residues L12, F15, V17, and H18, forming a flat 
hydrophobic surface patch on the fibril surface (Fig. 4C). A large amount of LPCs bound to this 
site (i.e., the largest LPC cluster of ~100 lipids in Fig.  4A) and formed a half-worm like 
morphology. LPC monomers could fit onto the groves between two consecutive β-strands (e.g., 
LPCs highlighted in spherical representation in Fig. 4C). The other binding site (formed by 
residues N3, A5 and Y37) was smaller and curved and the bound LPCs remained in the micelle 
morphology (Fig. 4D). Although simulations with the fibril fixed could not capture remodeling of 
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the fibril by LPCs, the strong LPC-fibril binding suggests that LPC could coat the fibril and bundle 
multiple fibrils into a braided structure as observed in TEM (Fig. 1B). This can also explain the 
slightly reduced ThT intensity but increased β sheet content observed for IAPP fibrillisation in the 
presence and absence of LPC < CMC (Fig. 1A vs. 1C, middle panel), as the strong binding of LPC 
monomers onto IAPP fibrils and protofibrils would sterically hinder ThT dye from binding thereby 
reducing its fluorescence. The combined ThT, CD, TEM and DMD results suggest that LPC 
monomers accelerated IAPP binding.    
Conclusion 
The uncovered phenomenon of IAPP aggregation inhibition by micellar LPC offers a new 
mechanism to the existing models of IAPP stabilisation by insulin, low pH, metal ions,1 or by zinc-
C-peptide-IAPP complexation.7 Interestingly, although not directly related to this study, it has been 
shown in the literature that whey protein α or β caseins, usually present in the form of micelles 
through mutual hydrophobic and electrostatic interactions, show a chaperone-like activity in 
inhibiting amyloid beta and insulin from aggregation through mechanisms not yet understood.37,38 
Differently from cell membranes and SDS micelles that are net negative, zwitterionic LPCs readily 
disperse in water as ultrasmall micelles and subsequent interact with IAPP to halt the latter’s 
aggregation. Lastly, some LPC species are nearly 5 times more concentrated in the β-cell secretory 
granules compared to the rest of the cell, and are downregulated some 40-60% after glucose 
stimulation39 suggesting a connection between LPC abundance and IAPP activity. These unique 
physicochemical characteristics of LPC may be crucial to IAPP stabilisation in vivo and instructive 
to the design and development of small molecules and nanoparticles against amyloidosis.  
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Materials and Methods  
Materials 
Human islet amyloid polypeptide (IAPP; 37 residues, 2-7 disulfide bridge, 3.9 kDa, >95% pure by 
HPLC) was obtained in lyophilised monomeric form from AnaSpec, and prepared in Milli-Q water 
at a stock concentration of 200 µM at room temperature with mixing immediately prior to use. 
Mature IAPP amyloids were aqueous solutions of IAPP incubated for more than 24 h. Thioflavin 
T (ThT) dye and L-α-Lysophosphatidylcholine (LPC; from Glycine max, >99% pure by TLC) 
were purchased from Sigma-Aldrich. LPC derived from soybean is primarily composed of 
unsaturated C-18 fatty acids; typically 40-60% linoleic, 25-30% palmitic, 10-12% oleic, 7-10% 
stearic and 4-6% linolenic acid. 
Thioflavin T (ThT) assay 
IAPP alone (25 µM) or in the presence of micellar and non-micellar LPC was mixed with 25 µM 
ThT dye in a black/clear bottom 96-well plate (Costar), with the remaining volume made up to 
100 µL with Milli-Q water where necessary. ThT fluorescence (Excitation: 440 nm/ Emission: 
485 nm) was then read every 10 min for 24 h (144 time points) on an EnVision plate reader (Perkin 
Elmer). Error represents the standard error of mean of two independent experiments. Data was fit 
to a sigmoidal curve (least squares) using Prism (GraphPad). 
Transmission electron microscopy (TEM) and analysis 
Carbon-coated formvar copper grids (400 mesh, ProSciTech) were glow discharged to promote 
hydrophilicity. A 10 µL aliquot of IAPP (25 µM) in the presence or absence of LPC was placed 
on the grid and allowed to adsorb for 60 s. The remaining solution was then drawn off and the grid 
washed twice in 10 µL of Milli-Q water. The grid was then touched to 5 µL 1% uranyl acetate (in 
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Milli-Q water), the solution immediately drawn off, and the grid then placed onto a 5 µL droplet 
of 1% uranyl acetate to stain for 15 s. Any remaining liquid was then drawn off and the sample 
allowed to dry. Grids were imaged using Tecnai TF20 (FEI) and JEOL 2000FX transmission 
electron microscopes. Fibril diameter analysis was undertaken using GMS 3 (Gatan), with the 
sample size as 150 data points. Statistical analysis was performed with Prism (GraphPad), utilising 
a one-way ANOVA with Tukey’s correction. Statistical significance was determined as p < 0.05.  
Circular dichroism (CD) spectroscopy 
Experiments were performed on a Chirascan CD spectrometer (Applied Photophysics), with 
spectra read from 190-260 nm. Prior to sample loading, a baseline with no cuvette was run. 300 
µL of 25 µM IAPP in Milli-Q water, alone or in the presence of LPC above (2 mM) and below 
(25 µM) the CMC, was placed in a cuvette with a 0.1 cm pathlength and CD analysis was run at 0 
h, 2.5 h and 24 h time points. Between samples, cuvettes were washed more than 5× with distilled 
water. Reads are an average of 3 repeats. Raw data were offset to zero and normalized against the 
spectra of Milli-Q water for IAPP spectra, and against LPC alone at each respective concentration 
for IAPP-LPC mixed samples (Fig. S2). Data were then de-convoluted with CDNN software to 
give a final relative percentage content of secondary structure. 
Discrete molecular dynamics (DMD) simulations  
DMD is a special type of molecular dynamics algorithm where conventional continuous potentials 
are replaced by optimized step-wise potential functions.40,41 A more comprehensive description of 
the DMD algorithm was published elsewhere.27 In brief, the united-atom model represents all 
molecules where all heavy atoms and polar hydrogen atoms are explicitly modeled. An implicit 
solvent model was adopted in our system. The interatomic interactions included van der Waals, 
solvation, electrostatic interactions and hydrogen bond. The solvation energy was adopted by the 
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Lazaridis-Karplus implicit solvent model, EEF1.42 The distance- and angular-dependent hydrogen 
bond interaction was modeled using a reaction-like algorithm.43 Screened electrostatic interactions 
were computed by the Debye-Hückel approximation. A Debye length of 1 nm was used by 
assuming a water dielectric constant of 80 and a monovalent electrolyte concentration of 0.1 M. 
The Anderson’s thermostat was used to maintain constant temperature. 
The structural coordinates for IAPP peptides were obtained from the protein bank (PDB code: 
5MGQ). For peptides and LPC, basic and acidic amino acids and nitrogen were assigned charges 
corresponding to their titration states at physiological condition, i.e. Arg and Lys residues were 
assigned +1, Asp and Glu were assigned -1, while His was neutral. Counter ions (Cl-) were added 
to maintain the net charge of the systems zero and accounted for possible counter-ion 
condensation. 
A large fibril model was constructed with 40 IAPPs forming a two-layered fibril using the solid-
state NMR-derived constraints,36 which was assigned a 1.5-degree twist between consecutive 
IAPP beta-sheets. Specifically, side chains of Gln10, Leu12, Asn14 and Leu16 were located 
inward to the beta-sheet formed by residues 28-37. The side chains of Arg11, Ala13 and Phe15 in 
the protofibril were buried to form the fibril (Fig. S3). Using the same proximity constraints, DMD 
simulations were performed to relax the model structure until the system’s potential energies 
reached equilibrium at 300 K. As the model fibril comprised of 40 IAPP monomers, the fibril was 
fixed during DMD simulations of its binding with LPCs.  
All simulations were conducted at 300 K. To maintain the same peptide concentration in the 
systems of LPC monomers and micelles interacting with peptides (molar ratios of 24:6 and 2:2, 
respectively), cubic simulation boxes with equal dimensions of 183.0 and 126.8 Å were used 
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correspondingly. The periodic boundary condition was applied in all simulations. For each 
molecular system, 20 independent simulations were performed with different initial inter-
molecular distances and orientations to avoid bias. For data analysis, an inter-atomic distance 
cutoff of 5.0 Å was used to define an atomic contact. 
By initially positioning linear LPCs evenly in a spherical arrangement with the tails pointing 
inwards and heads outwards, relaxation simulations were performed at 300 K. The equilibrated 
values of radius of gyration, Rg, were evaluated for micelles with 25 to 60 LPCs, with intervals of 
5 for a total of 8 systems. Using the simple relationship between radius r and Rg, 𝑟 = √5/3𝑅𝑔, 
we found that 50 LPCs resulted in a spherical micelle structure of ~4 nm in diameter. The pre-
formed micelle structure was used to study its effect on IAPP self-association. 
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FIGURES AND CAPTIONS  
 
Figure 1. Effects of micellar (> CMC) and non-micellar (< CMC) LPC on IAPP fibrillation 
and amyloid remodelling. Concentrations of IAPP (25 µM), LPC < CMC (25 µM) and > CMC 
(2 mM) were fixed in all experiments. (A) ThT fluorescence assay of IAPP and LPC alone (both 
above and below the CMC) or as mixed samples, with sigmoidal least-squares fit (dotted lines); 
error = SEM. (B) TEM imaging of IAPP and IAPP amyloids after 24 h incubation with or without 
LPC, scale = 100 nm. (C) IAPP secondary structures in the presence and absence of LPC as 
determined through circular dichroism spectroscopy. Lines are intended to guide the eye. (D) 
Diameter frequencies of IAPP amyloid fibrils with Gaussian least-squares fit, **** p < 0.0001 
(one-way ANOVA with Tukey’s correction).  
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Figure 2. IAPP-LPC micelle interaction. (A) Average contact number between pair-wise IAPPs, 
Ncontact (top) and binding frequency between IAPP and LPC micelle, Pbind (lower) as a function of 
time. (B) Binding frequency Pbind of each IAPP residue with hydrophobic and hydrophilic regions 
of LPC micelle derived from the IAPP-LPC complexes. Residues with strong binding to the 
hydrophobic core of LPC micelle are highlighted as sticks in a representative micelle-bound IAPP 
structure (inset). (C) Secondary structure contents, Psecond, of IAPP with and without LPC micelle. 
(D) The α-helix propensity Phelix of each IAPP residue with and without LPC micelle. (E, F)  The 
2D-PMF of IAPP with and without LPC micelle at T = 300 K as a function of radius of gyration, 
Rg, and the number of residues in helical conformation, Nhelix. The typical structures corresponding 
to energy basins indicated by arrows are shown as inset where IAPP (cyan) is illustrated in carton 
and LPC micelle (orange) in spherical representation. 
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Figure 3. IAPP-soluble LPC interaction. (A) Average number of IAPP clusters as a function of 
simulation time in the presence and absence of LPCs. (B) Mass-weighted histograms of IAPP 
cluster sizes computed from the last 25 ns of corresponding simulations. (C) Binding frequency, 
Pbind, of each IAPP residue with hydrophobic and hydrophilic regions of LPC derived from the 
IAPP-LPC complexes. For comparison, binding with the hydrophobic region of LPC micelle is 
also shown as a dash line. (D) Snapshot structures along a DMD trajectory showing the co-
aggregation process, where IAPPs (cyan) are in carton representation and LPCs in spherical 
representation.  
 
 21 
 
Figure 4. IAPP amyloid-soluble LPC interaction. (A) Mass-weighted histograms of LPC cluster 
sizes in solution and bound to fibril (inset) computed from IAPP amyloid fibril and LPC 
simulations. (B) Binding probability, Pbind, of each IAPP residue in the fibril with LPC. Two main 
binding sites for LPC on IAPP amyloid fibrils correspond to half-worm like (C) and micelle (D) 
morphologies, with the binding surfaces shown as insets. The fibril is coloured by the binding 
probability of IAPP residues with LPC: orange (0.7-1), yellow (0.3-0.7), grey (0.1-0.3) and blue 
(<0.1) indicating high to low binding probabilities. LPCs are highlighted as spherical 
representation in panel (C) from top view to show LPCs fit onto groves between consecutive β-
strands.  
